Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on COVID-19

Experts say strict new FDA protocol for vaccine approval is ‘dangerous and irresponsible’

Lead FDA vaccine regulator announced new approval process after claiming Covid vaccine had killed 10 children

The Guardian - US · Nov 29, 2025

Top FDA official threatens to crack down on vaccine approvals

The internal memo comes after an internal agency review linked COVID-19 vaccines to the deaths of 10 children.

Axios · Nov 29, 2025

Louisiana official who called Covid-19 vaccines ‘dangerous’ given key CDC post

Ralph Abraham appointed deputy director as RFK Jr continues to reshape US federal health leadership

The Guardian - US · Nov 25, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk

The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) Cohort 8 of ENDEAVOR (Study 9001-103).

Benzinga · Nov 25, 2025

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer AG (OTC:BAYRY) released topline results from the Phase 3 OCEANIC-STROKE study, with its investigational, once daily, oral FXIa inhibitor asundexian.

Benzinga · Nov 24, 2025

Harvard Study Reveals Eight Distinct Long Covid Trajectories as 20M Americans Still Battle Symptoms

Harvard researchers have identified eight long COVID trajectories in a major NIH-backed study, offering new insight into how symptoms change over 15 months.

International Business Times UK · Nov 24, 2025

There are 8 patterns for long COVID symptoms. Here's what they are

Findings come from the NIH-backed RECOVER Initiative.

Axios · Nov 22, 2025

Read news from The Economist, FT, and more,
with one subscription

Contineum Therapeutics' Multiple Sclerosis Trial Disappoints, But Analyst Sees Other Assets Driving Value

Contineum Therapeutics, Inc. (NASDAQ:CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS).

Benzinga · Nov 21, 2025

Deadly mpox variant Clade 1b spreads in Europe amid rush for vaccines

Mpox cases continue to rise in parts of Africa, three years after a major outbreak infected nearly 100,000 people

The Independent UK · Nov 21, 2025

Nearly 6,000 Londoners died due to Covid within weeks after 'deadly delay' in ordering lockdown

Boris Johnson’s government was slammed by the Covid Inquiry for its ‘chaos’ and the ‘toxic’ culture in No10

Evening Standard · Nov 21, 2025

Ozempic could redefine Thanksgiving across the country as users’ appetites dwindle: ‘I don’t want to hurt anyone’s feelings’

‘I will just grab the dish and not eat it,’ one GLP-1 medication user said of her favorite Thanksgiving dish

The Independent UK · Nov 21, 2025

Disease fears as Argentina child vaccination rates hit historic lows

Sharp drop since 2024 in country regarded as a Latin American leader in childhood and adolescent immunisation

The Guardian - US · Nov 19, 2025

Strange changes found in blood of long Covid patients

Tiny clots appeared larger-than-normal in long Covid patients, study finds

The Independent UK · Nov 17, 2025

‘The White Lotus’ saw a surge in searches for one anxiety drug. Doctors give a stark warning

Taking lorazepam and drinking, like characters did on the show, can put people into a coma, doctors warn

The Independent UK · Nov 14, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Nov 12, 2025

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

On Wednesday, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Benzinga · Nov 10, 2025

AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study

AnaptysBio Inc. (NASDAQ:ANAB) on Monday released data from the Phase 2 trial of rosnilimab for moderate-to-severe ulcerative colitis.

The Independent UK · Nov 10, 2025

Scientists create no-needle vaccine for whooping cough

There were 502 cases of whooping cough between January and June this year in England, according to UKHSA

The Independent UK · Nov 4, 2025

Covid jab presents less harm for patients than the virus itself, study reveals

It comes amid previous concerns about potential harm from the jab

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Nov 4, 2025

Pfizer COVID-19 vaccine sales drop 25% after confusing government guidance on the shot

Previously, fall is when Americans would typically receive their vaccines

The Independent UK · Nov 3, 2025

Voices: ‘It’s like the NHS would rather pay a hospital bill over a cheap jab’: Readers react to Covid vaccine cuts

YOUR VIEWS: Our community has criticised the government’s decision to restrict free Covid boosters, describing it as unfair, confusing, and short-sighted, and urged a review of eligibility to protect vulnerable people still at risk

The Guardian - AU · Nov 2, 2025

A fatal drop: what do we know about the drugs, 500 times stronger than heroin, taking Australian lives?

Only a few years after first being detected in Australia, nitazenes have been found in everything from vapes to fake heroin – and the death toll is rising

The Guardian - US · Nov 1, 2025

US public health officials vigilant as newer mpox variant detected

Risk to general public is low but cases in California suggest virus is spreading undetected in some communities

The Independent UK · Oct 31, 2025

Health officials urge parents to vaccinate children amid ‘deeply worrying’ rise in meningitis cases

Meningitis can cause life-threatening sepsis and result in permanent damage to the brain or nerves if not treated quickly

The Guardian - UK · Oct 29, 2025

I was happy to drop my pants for medical science (and money). Come on, gen Z – it’s your turn

Young people are eschewing medical trials, to their own detriment. Maybe my tales of pills, tubes and paydays can inspire a generation, says freelance writer Rich Pelley

The Guardian - US · Oct 27, 2025

Threat to US vaccines as CDC staff supporting key advisory panel laid off

Critics say scientists ‘held hostage’ by RFK Jr as changes mean vaccine development and guidance in peril

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Cambridge

260 stories

BMY

198 stories

Harvard Medical School

149 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.